-
Levy Rytter posted an update 1 year, 6 months ago
Oncotype Dx® (ODX) is the most used prognostic and predictive assay for ER+breast cancer (BCa) and is categorized into low (< 18), intermediate (18 to 30), or high (≥31) risk of recurrence. Prosigna® is a prognostic signature to estimate distant recurrence-free survival for stage I/II, ER+ cancer in postmenopausal women treated with adjuvant the…[Read more]
-
Levy Rytter posted an update 1 year, 6 months ago
Iron is an essential component for growth and development. Despite relative abundance in the environment, bioavailability of iron is limited due to oxidation by atmospheric oxygen into insoluble ferric iron. Filamentous fungi have developed diverse pathways to uptake and use iron. In the current study, a putative iron utilization gene cluster…[Read more]
-
Levy Rytter posted an update 1 year, 7 months ago
Efficacious transmittal of COVID-19 has compelled numerous countries worldwide to embrace temporary yet dramatic measures such as locking down entire cities, restricting all forms of transportation, imposing lockdowns, maintaining social distancing etc. These actions have considerably enhanced the quality of ambient air and water. India, being a…[Read more]
-
Levy Rytter became a registered member 1 year, 7 months ago

